These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 11145219)

  • 1. Protein instability in poly(lactic-co-glycolic acid) microparticles.
    van de Weert M; Hennink WE; Jiskoot W
    Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G; Park TG
    J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.
    Schwendeman SP
    Crit Rev Ther Drug Carrier Syst; 2002; 19(1):73-98. PubMed ID: 12046892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
    Morlock M; Kissel T; Li YX; Koll H; Winter G
    J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
    Walter E; Moelling K; Pavlovic J; Merkle HP
    J Control Release; 1999 Sep; 61(3):361-74. PubMed ID: 10477808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
    Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
    Ertl B; Platzer P; Wirth M; Gabor F
    J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
    Saez A; Guzmán M; Molpeceres J; Aberturas MR
    Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.
    Nam YS; Park TG
    J Microencapsul; 1999; 16(5):625-37. PubMed ID: 10499842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination.
    Giunchedi P; Conti B; Scalia S; Conte U
    J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
    Chen W; Lu DR
    J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.
    Costantino HR; Firouzabadian L; Hogeland K; Wu C; Beganski C; Carrasquillo KG; Córdova M; Griebenow K; Zale SE; Tracy MA
    Pharm Res; 2000 Nov; 17(11):1374-83. PubMed ID: 11205730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F; Ertl B; Wirth M; Mallinger R
    J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure formation in injectable poly(lactide-co-glycolide) depots.
    Wang L; Kleiner L; Venkatraman S
    J Control Release; 2003 Jul; 90(3):345-54. PubMed ID: 12880701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P; Corradin G; Merkle HP; Gander B
    J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.